newsfilter
← Latest News
Business Wire·

France Expands National AAC Access for Agenus' Botensilimab + Balstilimab for Ovarian Cancer and Soft-Tissue Sarcomas

Updated national AAC protocol supports hospital-based, fully-reimbursed compassionate access across three solid tumor settings Agenus Inc. (NASDAQ:AGEN), a leader in immuno-oncology innovation, today announced that